SEC Form D private-offering filing

AeroRx Therapeutics, Inc.

A new SEC Form D private-offering notice from La Jolla, CA, a $20,751,992 filer-stated offering target in Biotech. The source filing is one click away.

AeroRx Therapeutics, Inc. site↗ Verified via SEC Form D

Clinical-stage biopharmaceutical company developing nebulized combination therapies, including AERO-007, for chronic obstructive pulmonary disease (COPD).

Filed 2025-10-10Filed to raise $20,751,992First money in 2025-09-25Raised so far $10,376,003HQ (as filed) La Jolla, CASector Biotech ✓Stage (inferred) EarlyCall status Call-ready
Source linked the Form D on EDGAR↗Website verified aerorxtx.com↗Named in the filing 6 executives & directors
Open this row on the live feed →More new filings in California →More Biotech filings →

This is a public SEC Form D private-offering notice, the filer's own statement to the SEC. Amounts are offering targets, not confirmed closes. Takeoff Radar pulls Form D nightly from EDGAR and links every filing to its source.